CADM1 and hepatocellular carcinoma: Nonetheless, the oncogenic role of miR-1246 has been reported in melanoma by conferring resistance to BRAF inhibitors [36] or enhancing migration and invasion through the adhesion molecule CADM1 in hepatocellular cancer [37].